For adults taking GLP-1 medications, consult with your physician before taking any dietary supplements
We believe in empowering our patients with knowledge and resources
Weight loss a healthy approach FAQs about body mass index (BMI) Contrave (naltrexone/buproprion) Duromine (phentermine) Saxenda (liraglutide) Xenical (orlistat) Wegovy (semaglutide) Brochures Weight loss medicines: Tips for better results [PNG, 363 KB] Healthify He Puna Waiora, NZ, 2026 Healthy eating, active living(external link) HealthEd, NZ, 2021 Behind the hype weight loss diets(external link) Health Ed and Health Promotion Agency, NZ, 2019 Apps/tools References Obesity and weight-loss management(external link) Research Review, NZ, 2020 Weight loss the options and the evidence(external link) BPAC, NZ, 2022 Clinical guidelines for weight management of New Zealand adults(external link) Ministry of Health, NZ, 2017 Contrave(external link) Medsafe datasheet, NZ Pavli P, Triantafyllidou O, Kapantais E, et al

CMS has issued guidance to Medicare Part D plans stating that anti-obesity medications that receive FDA approval for an additional medically accepted indication can be considered a Part D drug for that specific use, the spokesperson explained, adding that Medicare coverage is still not available to patients only taking the drug to lose weight
doi: 10.1016/j.atherosclerosis.2018.07.014 81 SinghGBZhangYBoiniKMKokaS
However, the side effects of glutathione injection can include headaches, nausea, allergic reactions, or skin irritation if taken without proper medical supervision